Important research findings, therapy advances, and other events related to pulmonary hypertension were reported daily in Pulmonary Hypertension News during 2017. Now that the year is over, it’s time to briefly review the articles that appealed most to our readers. Here are the Top 10 most-read articles of 2017, with a brief description of…
Search results for:
[vc_row][vc_column][vc_column_text]PRX-08066, also known as Maleic acid, is a novel, experimental, selective 5-hydroxytryptamine receptor 2B (5-HT2BR) antagonist targeted at treating patients with Pulmonary Arterial Hypertension (PAH) in order to improve exercise ability and reduce clinical disease progression. Currently under development by Epix Pharmaceuticals Inc., the drug is chemically known as 5-((4-(6-Chlorothieno…
It’s no surprise that sometimes people end up saying things they don’t want to — or mean to. Especially when they’re talking to someone with a disease like pulmonary hypertension (PH), that is not fully understood by those who don’t live with it. Pulmonary hypertension is a chronic illness, and…
Testing for Pulmonary Hypertension
Pulmonary hypertension (PH) is a rare, chronic disease that occurs when pulmonary arteries that carry blood from the heart to the lungs become narrow and tough, forcing the right side of the heart to work much harder to pump blood back to the lungs. The result ranges from shortness of breath to heart…
On June 12, 2015 a PhD thesis entitled “Vascular remodeling in pulmonary hypertension” will be presented by Ya-Ting Chang at the Karolinska Institutet in Sweden. Chang’s research focuses on pulmonary hypertension, a life-threatening condition of multifactorial etiology, characterized by the increase of blood pressure in the pulmonary arteries that…
A study published in the journal Respiratory Medicine Case Reports revealed a case where a patient with idiopathic pulmonary fibrosis (IPF) was successfully treated for severe pulmonary hypertension (PH) with bosentan. The study is entitled “Bosentan for…
Managing Challenging Cases of Pulmonary Hypertension
Because there are many different types of pulmonary hypertension (PH), doctors face many challenges when treating patients. In this video from PAH.TV, an expert panel of pulmonologists discuss some of the various complex pulmonary hypertension cases they have worked on and how to best manage these types of patients. Find…
Image Courtesy of TomTec Imaging Systems TomTec Imaging Systems, a Munich-based company specializing in medical imaging and information management software with a focus on ultrasound technologies, has just announced its groundbreaking 4D RV-Function© software that allows extensive assessment of the right ventricle (RV) of the heart. This diagnostic and…
11 Pulmonary Hypertension Related Diseases
The rare and severe lung disease called pulmonary hypertension (PH) affects the pulmonary arteries, causing high blood pressure. The pulmonary arteries transport the blood from the right heart ventricle to the lungs, but when affected by the disease, they become narrowed and thickened. The hearts…
[vc_row][vc_column][vc_column_text]Pulmonary hypertension (PH) is a rare, life-threatening condition characterized by high blood pressure in the lungs and measured according to a resting mean pulmonary arterial pressure of 25 mmHg or greater at right heart catheterization. The disease is associated with damage to the pulmonary arteries, which are responsible for transporting blood…
Pulmonary hypertension (PH) is a rare but severe condition characterized by high blood pressure that affects pulmonary arteries – the vessels responsible for transporting blood from the heart to the lungs. Because of the disease, the arteries become narrowed and thickened which makes it difficult for the heart to properly pump…
In this video from 2012 by UT Health Northeast, we find the renowned University of Texas Health Science Center pulmonologist Dr. Julie Philley briefly explaining pulmonary hypertension, defining PH, pointing to causes, symptoms, how to diagnose, and general differences between pulmonary hypertension and “regular”…